U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H9Cl3N2O
Molecular Weight 315.582
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRICLOCARBAN

SMILES

ClC1=CC=C(NC(=O)NC2=CC=C(Cl)C(Cl)=C2)C=C1

InChI

InChIKey=ICUTUKXCWQYESQ-UHFFFAOYSA-N
InChI=1S/C13H9Cl3N2O/c14-8-1-3-9(4-2-8)17-13(19)18-10-5-6-11(15)12(16)7-10/h1-7H,(H2,17,18,19)

HIDE SMILES / InChI

Molecular Formula C13H9Cl3N2O
Molecular Weight 315.582
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: Description was created using several sources including: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm517478.htm; http://www.fda.gov/downloads/aboutfda/reportsmanualsforms/reports/economicanalyses/ucm519798.pdf; https://www.ncbi.nlm.nih.gov/pubmed/22626523; https://www.ncbi.nlm.nih.gov/pubmed/21131331; http://www.ncbi.nlm.nih.gov/pubmed/?term=12534815

Triclocarban is a triclosan analogue with an antibmicrobial property. It has been used in a wide range of personal cleansing products including deodorant and bar soaps, deodorants, detergents, cleansing lotions, and wipes. In US triclocarban was approved for marketing of over-the-counter (OTC) consumer antiseptic wash products. But on September 2, 2016 U.S. Food and Drug Administration banned containing triclocarban and triclosan consumer antiseptic wash products from further marketing in USA because of a potential damage to human health, resulting from extended exposure to antiseptic active ingredients on a regular bases. However the new rule does not not affect consumer hand “sanitizers” or wipes, or antibacterial products used in health care settings. Triclocarban is a limited spectrum antibacterial agent effective in vitro against some strains of staphylococcus, streptococcus, and enterococcus bacteria. The minimum inhibitory concentration has been found to range from 0.5 to 8 mg/L for these various strains. Triclocarban can act by non-specific membrane-destabilizing mechanism; also was suggested, that similar to triclosan, Triclocarban exerts its effect by inhibiting the activity of enoyl-(acyl-carrier protein) (ACP) reductase, widely distributed in bacteria, fungi and plants. As a result, this agent interrupts cell membrane synthesis and leads to bacterial growth inhibition.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
Dial® soap

Approved Use

Antibacterial Soap used to protect skin from bacterial infections
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
8.6 h
103 μg single, intravenous
dose: 103 μg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
TRICLOCARBAN blood
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
Doses

Doses

DosePopulationAdverse events​
9 % 1 times / day multiple, topical
Highest studied dose
Dose: 9 %, 1 times / day
Route: topical
Route: multiple
Dose: 9 %, 1 times / day
Sources:
healthy, 21 to 65 years old
n = 10
Health Status: healthy
Age Group: 21 to 65 years old
Sex: M
Population Size: 10
Sources:
Other AEs: Skin irritation...
AEs

AEs

AESignificanceDosePopulation
Skin irritation grade 1
9 % 1 times / day multiple, topical
Highest studied dose
Dose: 9 %, 1 times / day
Route: topical
Route: multiple
Dose: 9 %, 1 times / day
Sources:
healthy, 21 to 65 years old
n = 10
Health Status: healthy
Age Group: 21 to 65 years old
Sex: M
Population Size: 10
Sources:
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer






Drug as perpetrator​Drug as victim
PubMed

PubMed

TitleDatePubMed
Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria.
2003
Simultaneous determination of chlorinated bacteriostats in cosmetic and pharmaceutical products.
2005 May-Jun
Detection of triclocarban and two co-contaminating chlorocarbanilides in US aquatic environments using isotope dilution liquid chromatography tandem mass spectrometry.
2007 Jan
Snail bioaccumulation of triclocarban, triclosan, and methyltriclosan in a North Texas, USA, stream affected by wastewater treatment plant runoff.
2008 Aug
Growth-inhibiting effects of 12 antibacterial agents and their mixtures on the freshwater microalga Pseudokirchneriella subcapitata.
2008 May
Determination of household chemicals using gas chromatography and liquid chromatography with tandem mass spectrometry.
2008 May 9
Runoff of pharmaceuticals and personal care products following application of dewatered municipal biosolids to an agricultural field.
2009 Aug 1
Fate of organohalogens in US wastewater treatment plants and estimated chemical releases to soils nationwide from biosolids recycling.
2009 Dec
Adsorption and degradation of triclosan and triclocarban in soils and biosolids-amended soils.
2009 Jun 10
Effect of triclosan and triclocarban biocides on biodegradation of estrogens in soils.
2009 Nov
On-line solid-phase extraction of large-volume injections coupled to liquid chromatography-tandem mass spectrometry for the quantitation and confirmation of 14 selected trace organic contaminants in drinking and surface water.
2009 Nov 27
Occurrence and risks of triclosan and triclocarban in the Pearl River system, South China: from source to the receiving environment.
2010 Jul 15
Self-reported chemicals exposure, beliefs about disease causation, and risk of breast cancer in the Cape Cod Breast Cancer and Environment Study: a case-control study.
2010 Jul 20
Analysis of triclosan and triclocarban in soil and biosolids using molecularly imprinted solid phase extraction coupled with HPLC-UV.
2010 Jul-Aug
Quantitative gene monitoring of microbial tetracycline resistance using magnetic luminescent nanoparticles.
2010 Jun
Quantitative determination of triclocarban in wastewater effluent by stir bar sorptive extraction and liquid desorption-liquid chromatography-tandem mass spectrometry.
2010 Mar 12
Aquatic hazard assessment for pharmaceuticals, personal care products, and endocrine-disrupting compounds from biosolids-amended land.
2010 Oct
Triclocarban and triclosan biodegradation at field concentrations and the resulting leaching potentials in three agricultural soils.
2010 Sep
Effects of triclocarban on the transcription of estrogen, androgen and aryl hydrocarbon receptor responsive genes in human breast cancer cells.
2013 Aug
Patents

Sample Use Guides

Use Dial® soap containing 0.30% triclocarban for hand and body wash
Route of Administration: Other
To study effects of antimicrobial agents on the growth of P. aeruginosa at 37°C triclocarban at concentrations of 0 - 5 ug/ml were used
Substance Class Chemical
Created
by admin
on Fri Dec 15 15:22:17 GMT 2023
Edited
by admin
on Fri Dec 15 15:22:17 GMT 2023
Record UNII
BGG1Y1ED0Y
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TRICLOCARBAN
HSDB   INCI   INN   MART.   MI   USAN   USP-RS   WHO-DD  
INCI   INN   USAN  
Official Name English
UREA, N-(4-CHLOROPHENYL)-N'-(3,4-DICHLOROPHENYL)-
Systematic Name English
1-(4-CHLOROPHENYL)-3-(3,4-DICHLOROPHENYL)UREA
Systematic Name English
NSC-72005
Code English
TRICLOCARBAN [MI]
Common Name English
TRICLOCARBAN [USP-RS]
Common Name English
TRICLOCARBAN [HSDB]
Common Name English
TRICLOCARBAN [USP MONOGRAPH]
Common Name English
Triclocarban [WHO-DD]
Common Name English
TRICLOCARBAN [INCI]
Common Name English
triclocarban [INN]
Common Name English
3,4,4'-TRICHLOROCARBANILIDE
Common Name English
TRICLOCARBAN [USAN]
Common Name English
TRICLOCARBAN [MART.]
Common Name English
Classification Tree Code System Code
EPA PESTICIDE CODE 27901
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
NCI_THESAURUS C28394
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
Code System Code Type Description
DRUG CENTRAL
3630
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
MERCK INDEX
m11089
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY Merck Index
INN
2017
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
NCI_THESAURUS
C47770
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
ECHA (EC/EINECS)
202-924-1
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
RXCUI
38609
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY RxNorm
DAILYMED
BGG1Y1ED0Y
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
PUBCHEM
7547
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
WIKIPEDIA
TRICLOCARBAN
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
NSC
72005
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
HSDB
5009
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
RS_ITEM_NUM
1681800
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
CHEBI
48347
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
MESH
C009540
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
FDA UNII
BGG1Y1ED0Y
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
DRUG BANK
DB11155
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
SMS_ID
100000077518
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL1076347
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
CAS
101-20-2
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
EVMPD
SUB11271MIG
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID4026214
Created by admin on Fri Dec 15 15:22:17 GMT 2023 , Edited by admin on Fri Dec 15 15:22:17 GMT 2023
PRIMARY
Related Record Type Details
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
METABOLIC ENZYME -> SUBSTRATE
MAJOR
METABOLIC ENZYME -> SUBSTRATE
MAJOR
Related Record Type Details
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
IN VITRO
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
URINE
Related Record Type Details
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
IMPURITY -> PARENT
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Tmax PHARMACOKINETIC ORAL ADMINISTRATION